^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              24    10631001 10631002 11601006    
                            13031001 13991002 13991004    
                            13991007 13991009 16591006    
                            17601002 17601003 17601005    
                            17601007 17601012 17601014    
                            17661002 17661004 19731001    
                            19731002 19731006 19831001    
                            19831005 19831008 19901003    
      AVISITN          4    1 4 8 12                      
      trtn             3    1 2 3                         
      SSNRISN          2    1 2                           
      VISITTYN         1    1                             
      wk12             2    0 1                           
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     28
              Columns in Z                      0
              Subjects                         24
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              96
          Number of Observations Used              96
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       235.46796672                
          1              2       190.31510680      0.00010560
          2              1       190.31348152      0.00000004
          3              1       190.31348094      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5398
                UN(2,1)     id           0.2824
                UN(2,2)     id           0.6501
                UN(3,1)     id           0.2994
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,2)     id           0.5837
                UN(3,3)     id           1.0590
                UN(4,1)     id           0.3607
                UN(4,2)     id           0.3087
                UN(4,3)     id           0.5444
                UN(4,4)     id           0.5816


                        Fit Statistics

             -2 Res Log Likelihood           190.3
             AIC (Smaller is Better)         210.3
             AICC (Smaller is Better)        213.2
             BIC (Smaller is Better)         222.1
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         45.15          <.0001


                 Type 3 Tests of Fixed Effects
 
                           Num     Den
    Effect                  DF      DF    F Value    Pr > F

    BASE                     1      19      36.31    <.0001
    trtn                     2      19       0.18    0.8380
    wk12                     1      20       3.53    0.0748
    SSNRISN                  1      19       3.67    0.0706
    BASE*wk12                1      20       1.14    0.2979
    trtn*VISITTYN            0                             
    trtn*wk12                2      20       1.76    0.1974
    VISITTYN*wk12            0                             
    trtn*VISITTYN*wk12       0                             
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                     Subject'
                     s type
                     of visit            Standard
Effect         trtn  (N)       Estimate     Error    DF  t Value

trtn*VISITTYN  1     1          -0.4010    0.3211    19    -1.25
trtn*VISITTYN  2     1          -0.6098    0.2996    19    -2.04
trtn*VISITTYN  3     1          -0.5605    0.2876    19    -1.95

                      Least Squares Means
 
                            Subject'
                            s type
                            of visit
       Effect         trtn  (N)       Pr > |t|     Alpha

       trtn*VISITTYN  1     1           0.2268      0.05
       trtn*VISITTYN  2     1           0.0560      0.05
       trtn*VISITTYN  3     1           0.0662      0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                           Subject'
                           s type
                           of visit
      Effect         trtn  (N)          Lower       Upper

      trtn*VISITTYN  1     1          -1.0730      0.2709
      trtn*VISITTYN  2     1          -1.2369     0.01724
      trtn*VISITTYN  3     1          -1.1623     0.04128
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              16    10631001 10631002 11601006    
                            13031001 13991002 13991004    
                            13991007 13991009 17601005    
                            17601007 17601014 17661004    
                            19731002 19731006 19831001    
                            19901003                      
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         16
              Max Obs per Subject               4
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              76
          Number of Observations Used              64
          Number of Observations Not Used          12


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       159.11568539                
          1              2       130.61679901      0.00006206
          2              1       130.61598862      0.00000001
          3              1       130.61598843      0.00000000


                   Convergence criteria met.                    
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.6725
                UN(2,1)     id           0.3236
                UN(2,2)     id           0.6623
                UN(3,1)     id           0.3244
                UN(3,2)     id           0.6006
                UN(3,3)     id           1.1014
                UN(4,1)     id           0.4069
                UN(4,2)     id           0.3604
                UN(4,3)     id           0.5642
                UN(4,4)     id           0.6014


                        Fit Statistics

             -2 Res Log Likelihood           130.6
             AIC (Smaller is Better)         150.6
             AICC (Smaller is Better)        155.4
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             BIC (Smaller is Better)         158.3


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         28.50          0.0008


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   BASE                       1    12.3      21.86    0.0005
   trtn1                      0                             
   wk12                       0                             
   SSNRISN1                   1      12       2.93    0.1125
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   VISITTYN1                  0                             
   BASE*wk12                  1      13       0.98    0.3394
   trtn1*VISITTYN1            0                             
   trtn1*wk12                 0                             
   wk12*VISITTYN1             0                             
   trtn1*wk12*VISITTYN1       0                             


                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO  Week 4   -0.07514    0.4193  12.1    -0.18    0.8608
2 ACT-PBO  Week 4    Non-est                                   
1 ACT-PBO  Week 12    0.3349    0.4331  12.2     0.77    0.4540
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

2 ACT-PBO  Week 12   Non-est                                   

                           Estimates
 
       Label                Alpha       Lower       Upper

       1 ACT-PBO  Week 4     0.05     -0.9876      0.8373
       2 ACT-PBO  Week 4                                 
       1 ACT-PBO  Week 12    0.05     -0.6066      1.2765
       2 ACT-PBO  Week 12                                


 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              17    10631001 11601006 13031001    
                            16591006 17601002 17601003    
                            17601007 17601012 17661002    
                            17661004 19731001 19731002    
                            19731006 19831001 19831005    
                            19831008 19901003             
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         17
              Max Obs per Subject               4
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              96
          Number of Observations Used              68
          Number of Observations Not Used          28


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       175.80097641                
          1              2       136.93726308      0.00869312
          2              1       136.81872729      0.00027507
          3              1       136.81523776      0.00000050
          4              1       136.81523154      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.4752
                UN(2,1)     id           0.3540
                UN(2,2)     id           0.8800
                UN(3,1)     id           0.4904
                UN(3,2)     id           0.8398
                UN(3,3)     id           1.4468
                UN(4,1)     id           0.4447
                UN(4,2)     id           0.4821
                UN(4,3)     id           0.8583
                UN(4,4)     id           0.7922


                        Fit Statistics

             -2 Res Log Likelihood           136.8
             AIC (Smaller is Better)         156.8
             AICC (Smaller is Better)        161.2
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             BIC (Smaller is Better)         165.1


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         38.99          <.0001


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   BASE                       1      13      21.57    0.0005
   trtn2                      0                             
   wk12                       0                             
   SSNRISN1                   1      13       2.09    0.1719
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   VISITTYN1                  0                             
   BASE*wk12                  1      14       1.08    0.3169
   trtn2*VISITTYN1            0                             
   trtn2*wk12                 0                             
   wk12*VISITTYN1             0                             
   trtn2*wk12*VISITTYN1       0                             


                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO    Week 4   -0.1923    0.3699  12.9    -0.52    0.6120
2 ACT-PBO  Week 4     Non-est                                   
1 ACT-PBO  Week 12     0.1574    0.4125  12.6     0.38    0.7090
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

2 ACT-PBO  Week 12    Non-est                                   

                           Estimates
 
      Label                 Alpha       Lower       Upper

      1 ACT-PBO    Week 4    0.05     -0.9918      0.6073
      2 ACT-PBO  Week 4                                  
      1 ACT-PBO  Week 12     0.05     -0.7364      1.0513
      2 ACT-PBO  Week 12                                 


 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}
Key Seconda
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
